LESLIE F VARON, a director at $XRAY, bought 9,337 shares of the company on 11-24-2025 for an estimated $99,999. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 19.5%. Following this trade, they now own 57,342 shares of this class of $XRAY stock.
$XRAY Insider Trading Activity
$XRAY insiders have traded $XRAY stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $XRAY stock by insiders over the last 6 months:
- LESLIE F VARON purchased 9,337 shares for an estimated $99,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$XRAY Hedge Fund Activity
We have seen 237 institutional investors add shares of $XRAY stock to their portfolio, and 203 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 10,749,500 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $136,411,155
- NUANCE INVESTMENTS, LLC removed 8,987,359 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $142,719,260
- ARMISTICE CAPITAL, LLC added 5,234,587 shares (+1044.0%) to their portfolio in Q3 2025, for an estimated $66,426,909
- JACOBS LEVY EQUITY MANAGEMENT, INC added 4,003,606 shares (+662.0%) to their portfolio in Q3 2025, for an estimated $50,805,760
- D. E. SHAW & CO., INC. added 1,669,643 shares (+136.1%) to their portfolio in Q3 2025, for an estimated $21,187,769
- BRICKWOOD ASSET MANAGEMENT LLP added 1,496,935 shares (+5515.8%) to their portfolio in Q3 2025, for an estimated $18,996,105
- INVENOMIC CAPITAL MANAGEMENT LP added 1,425,637 shares (+48.7%) to their portfolio in Q3 2025, for an estimated $18,091,333
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$XRAY Analyst Ratings
Wall Street analysts have issued reports on $XRAY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 11/10/2025
- UBS issued a "Buy" rating on 08/08/2025
To track analyst ratings and price targets for $XRAY, check out Quiver Quantitative's $XRAY forecast page.
$XRAY Price Targets
Multiple analysts have issued price targets for $XRAY recently. We have seen 6 analysts offer price targets for $XRAY in the last 6 months, with a median target of $13.5.
Here are some recent targets:
- Michael Petusky from Barrington Research set a target price of $14.0 on 11/10/2025
- Lilia-Celine Lozada from JP Morgan set a target price of $12.0 on 11/07/2025
- Vik Chopra from Wells Fargo set a target price of $12.0 on 11/07/2025
- Kevin Caliendo from UBS set a target price of $23.0 on 10/28/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $13.0 on 10/08/2025
- Jonathan Block from Stifel set a target price of $17.0 on 08/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
